Anthem Blue Cross Blue Shield / Elevance (Commercial) · facet joint interventions
✓ conditional · commercial
Criteria checklist
0 of 6 ticked- enumerated: yes
- covered:
- name: Facet-mediated AXIAL spinal pain (cervical or lumbar)
- criteria:
- pain pattern: predominantly axial, NOT radiculopathy/myelopathy/neurogenic claudication (exception: facet synovial cyst)
- chronic pain min months: 3
- severity: >=3/10 AND inability to perform >=2 ADLs/IADLs
- regions: cervical (64490-64492) or lumbar (64493-64495) ONLY
- no prior fusion at level: yes
- investigational:
- thoracic facet procedures (except C7-T1, T12-L1)
- therapeutic intra-articular facet injection as default (allowed only for inflammatory arthropathy, denervation contraindicated, or synovial cyst)
- cooled/pulsed/cryo/chemical/laser/endoscopic neurolysis; RF <80C
- ultrasound guidance; facet prolotherapy/PRP; >1 spinal region per session
- required: yes
- min duration months: not stated in the policy
- min duration weeks: 6
- satisfied by:
- failed >=6 weeks (PT + >=1 complementary modality)
- contraindicated
- modalities named:
- physical therapy
- pharmacologic
- complementary (chiro/acupuncture/activity modification)
- required: no
- min duration days: not stated in the policy
- success criteria: not stated in the policy
- threshold is binding: no
- required: no
- must clear: no
- note posture: not required
- required before: radiofrequency neurotomy (64633-64636)
- count: 2
- anesthetic only: yes
- relief threshold pct: 80
- spacing: >=1 week apart; positive blocks valid for 6 months
- applies: yes
- diagnostic per region per 12mo: 4
- diagnostic per level per year: 2
- levels per session: 2
- rfa sessions per region per 12mo: 2
- repeat rfa requires: >=50% relief + ADL improvement for >=6 months
- excluded levels: C0-C1, C1-C2
Carelon (Anthem) facet criteria. Dual medial branch blocks (anesthetic only, >=1 week apart, each >=80% relief, valid 6 months) gate RFA — the >=80% threshold MATCHES Medicare (WPS L38841/CGS L38773). KEY divergences from Medicare: a SIX-WEEK conservative floor (not months), a closed cervical/lumbar region list with an axial-pain + >=2-ADL severity gate, and therapeutic intra-articular facet injection barred as a default (RFA preferred). Thoracic facet procedures are investigational except C7-T1/T12-L1. From the actual fetched Carelon PDF.
Ticks are a documentation aid — nothing is stored; they reset on reload.
Dot phrase
Lean narrative A&P attestation. `***` = fill-in. Fully self-contained — rendered from Carelon MSK01-0626.1 (Interventional Pain Management, Anthem-delegated), not from the Medicare phrase. The dual anesthetic-only blocks are the RFA gate — document both dates.
.FACETANTHEM Assessment: *** — facet-mediated chronic axial *** (cervical or lumbar only) pain present >=3 months, rated >=3/10, with inability to perform >=2 ADLs/IADLs. The pain is predominantly axial and is not radiculopathy, myelopathy, or neurogenic claudication (facet synovial cyst excepted); the index segment has not been previously fused. Medical necessity per Carelon MSK01-0626.1: conservative care has failed or was contraindicated over >=6 weeks this episode — physical therapy plus at least one complementary modality (chiropractic, acupuncture, or activity modification), with medications *** . Two diagnostic medial branch blocks were performed at the same level(s) *** , anesthetic only, >=1 week apart, each producing >=80% relief of the index pain (*** and ***); positive blocks remain valid 6 months. Blocks were limited to one spinal region per session and <=2 levels per session, within <=4 diagnostic blocks per region per 12 months and <=2 per level per year, under fluoroscopic or CT guidance. Plan: Medial branch thermal RF neurotomy at the confirmed level(s) *** (64633/64634 cervical; 64635/64636 lumbar), within <=2 RFA sessions per region per rolling 12 months. [If repeat:] the prior RFA gave >=50% relief with ADL improvement for >=6 months. Risks, benefits, and alternatives discussed; consent obtained.
Where this payor diverges from the Medicare baseline
Cautions
Prior-auth pathway
- required: yes
- pathway: Carelon Medical Benefits Management
Provenance
- authority:
- type: commercial_policy
- id: Carelon MSK01-0626.1
- title: Carelon Interventional Pain Management — Paravertebral Facet Injection / MBB / Neurolysis
- delegated by: Anthem / Elevance Health
- applies because: Anthem delegates facet-procedure UM to Carelon (formerly AIM)
- source: https://guidelines.carelonmedicalbenefitsmanagement.com/wp-content/uploads/2026/03/PDF-Interventional-Pain-Management-2026-06-14.pdf
- archived copy:
sources/carelon_interventional-pain-mgmt_2026-06-14.pdf(sha256 70ebcaf53e7b… — kept in the content repo, not served here) - effective: 2026-06-14 · payor last reviewed: 2026-06-14 · we verified: 2026-07-24 · v1
Change history
- 2026-07-24commercial cells: re-verify 27 source PDFs by SHA-256 (Carelon/eviCore/UHC/Cigna) - all unchanged vs committed archive; last_verified -> 2026-07-24
3615c231f0 - 2026-06-30Archive commercial source PDFs into sources/ + wire source_file/source_hash
c5466694c8 - 2026-06-28Add commercial Facet Joint cells: Anthem(Carelon), UHC, Cigna(eviCore)
962ec9816b